Abbott Laboratories
ABTAbbott Laboratories (ABT) is a global healthcare company that develops, manufactures, and markets a wide range of healthcare products, including pharmaceuticals, diagnostic tools, medical devices, and nutritional products. Founded in 1888, Abbott is known for innovative solutions in medical diagnostics, cardiovascular and neurology devices, and nutrition, serving patients and healthcare providers worldwide.
Dividend History
Investors can expect a dividend payout of $0.63 per share, scheduled to be distributed in 30 days on August 17, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 17, 2026 | $0.63 | 2026-07-15 | 2026-07-15 |
| May 15, 2026 | $0.63 | 2026-04-15 | 2026-04-15 |
| February 13, 2026 | $0.63 | 2026-01-15 | 2026-01-15 |
| November 17, 2025 | $0.59 | 2025-10-15 | 2025-10-15 |
| August 15, 2025 | $0.59 | 2025-07-15 | 2025-07-15 |
Dividends Summary
- Consistent Payer: Abbott Laboratories has rewarded shareholders with 91 dividend payments over the past 22 years.
- Total Returned Value: Investors who held ABT shares during this period received a total of $33.62 per share in dividend income.
- Latest Payout: The most recent dividend of $0.63/share was paid 64 days ago, on May 15, 2026.
- Yield & Schedule: ABT currently pays dividends quarterly with an annual yield of 2.46%.
- Dividend Growth: Since 2004, the dividend payout has grown by 157.1%, from $0.24 to $0.63.
- Dividend Reliability: ABT has maintained or increased its dividend for 55 consecutive payments.
Company News
Tech stocks extended their sell-off on July 16, 2026, with the Nasdaq Composite falling 1.47% amid growing AI spending concerns and escalating U.S.-Iran tensions. Micron Technology plunged nearly 6%, while semiconductor leaders like Nvidia and Broadcom declined. Taiwan Semiconductor Manufacturing fell despite record earnings. Abbott Laboratories ...
The semiconductor sector continued its fourth consecutive day of losses after Taiwan Semiconductor raised capital expenditure forecasts to $60-64 billion, sparking investor concerns about profitability. Memory chip stocks like SK Hynix and Micron plummeted, dragging down the Nasdaq and S&P 500. The Dow remained relatively stable as healthcare sto...
The global biochemistry analyzer market is projected to reach $8.18 billion by 2035, driven by increasing diagnostic testing demand, adoption of fully automated systems, artificial intelligence integration, and rising preventive screening programs. The market encompasses various product types, modalities, and applications across hospitals, diagno...
The global blood glucose monitoring system market is valued at USD 16.8 billion in 2025 and is projected to reach USD 39.4 billion by 2035, growing at a CAGR of 8.9%. Growth is driven by AI-enabled monitoring systems, increasing diabetes prevalence, and rising adoption of home healthcare solutions. Key players include Medtronic, Abbott, Dexcom, a...
The veterinary lab automation market is experiencing robust growth, expanding from $1.26 billion in 2025 to $1.36 billion in 2026 at an 8.4% CAGR, with projections to reach $1.9 billion by 2030. Growth is driven by rising demand for rapid diagnostics, AI integration, companion animal care expansion, and robotic workflow adoption. North America le...
